Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

Varsha Moudgal; Tania Little; Dina Boikov; Jose A. Vazquez

doi:10.1128/AAC.49.2.767-769.2005

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

Varsha Moudgal, Tania Little, Dina Boikov, Jose A. Vazquez

Research output: Contribution to journal › Article › peer-review

230 Scopus citations

Abstract

Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.

Original language	English (US)
Pages (from-to)	767-769
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	49
Issue number	2
DOIs	https://doi.org/10.1128/AAC.49.2.767-769.2005
State	Published - Feb 2005
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1128/AAC.49.2.767-769.2005

Cite this

@article{867bd31d36c841ff879f19a0e3fa7d3a,

title = "Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis",

abstract = "Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.",

author = "Varsha Moudgal and Tania Little and Dina Boikov and Vazquez, {Jose A.}",

year = "2005",

month = feb,

doi = "10.1128/AAC.49.2.767-769.2005",

language = "English (US)",

volume = "49",

pages = "767--769",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

AU - Moudgal, Varsha

AU - Little, Tania

AU - Boikov, Dina

AU - Vazquez, Jose A.

PY - 2005/2

Y1 - 2005/2

N2 - Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.

AB - Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.

UR - http://www.scopus.com/inward/record.url?scp=12944289674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944289674&partnerID=8YFLogxK

U2 - 10.1128/AAC.49.2.767-769.2005

DO - 10.1128/AAC.49.2.767-769.2005

M3 - Article

C2 - 15673762

AN - SCOPUS:12944289674

SN - 0066-4804

VL - 49

SP - 767

EP - 769

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 2

ER -

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this